What does CUSIP 29664W105 represent in this 13F holders report?

CUSIP 29664W105 is the security identifier for ESPR - Esperion Therapeutics, Inc. - COM used to aggregate holder disclosures.

How many institutions held ESPR - Esperion Therapeutics, Inc. - COM in Q2 2022?

128 institutional investors reported ESPR - Esperion Therapeutics, Inc. - COM for Q2 2022. Use the holders table for investor-level position and value details.

Esperion Therapeutics, Inc. - COM (ESPR)

CUSIP: 29664W105

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / COM
Shares outstanding: 258,506,508
Total 13F shares: 55,366,705
Share change: +3,601,199
Total reported value: $352,132,262
Put/Call ratio: 25%
Price per share: $6.36
Number of holders: 128
Value change: +$24,287,037
Number of buys: 62
Number of sells: 56

Quarterly Holders Quick Answers

What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 29664W105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WASATCH ADVISORS LP	13F	Company	3.2%	8,147,380	$37,804,000	—	31 Mar 2022	13F
Deep Track Capital, LP	13F	Company	2.3%	6,000,000	$27,840,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	1.7%	4,491,530	$20,841,000	—	31 Mar 2022	13F
Meditor Group Ltd	13F	Company	1.7%	4,468,835	$20,735,000	—	31 Mar 2022	13F
Bellevue Group AG	13F	Company	1.7%	4,299,164	$19,948,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	1.5%	3,763,740	$17,463,000	—	31 Mar 2022	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	1%	2,713,176	$12,589,000	—	31 Mar 2022	13F
Altium Capital Management LLC	13F	Company	0.97%	2,496,524	$11,584,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.48%	1,248,338	$5,792,000	—	31 Mar 2022	13F
BIOTECH TARGET N V	3/4/5	10%+ Owner	— class O/S missing	4,477,964	$5,575,065	—	24 May 2021	3/4/5
Paradigm Biocapital Advisors LP	13F	Company	0.45%	1,157,246	$5,370,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.43%	1,111,047	$5,155,000	—	31 Mar 2022	13F
Rhenman & Partners Asset Management AB	13F	Company	0.38%	981,582	$4,555,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.35%	916,438	$4,252,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.29%	753,840	$3,497,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.25%	637,436	$2,958,000	—	31 Mar 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.21%	537,856	$2,496,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.2%	525,840	$2,440,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.16%	422,200	$1,959,000	—	31 Mar 2022	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F	Company	0.16%	419,918	$1,948,000	—	31 Mar 2022	13F
Monaco Asset Management SAM	13F	Company	0.16%	419,262	$1,945,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.13%	340,899	$1,885,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.14%	370,922	$1,721,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.14%	369,511	$1,715,000	—	31 Mar 2022	13F
Pentwater Capital Management LP	13F	Company	0.14%	358,006	$1,661,000	—	31 Mar 2022	13F
Walleye Capital LLC	13F	Company	0.12%	306,681	$1,423,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.11%	292,778	$1,358,000	—	31 Mar 2022	13F
PINNACLE ASSOCIATES LTD	13F	Company	0.1%	259,783	$1,205,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.09%	224,222	$1,041,000	—	31 Mar 2022	13F
Swedbank AB	13F	Company	0.08%	217,000	$1,006,880	—	31 Mar 2022	13F
PICTET ASSET MANAGEMENT SA	13F	Company	0.07%	191,547	$889,000	—	31 Mar 2022	13F
TENOR CAPITAL MANAGEMENT Co., L.P.	13F	Company	0.07%	185,838	$862,000	—	31 Mar 2022	13F
PDT Partners, LLC	13F	Company	0.07%	174,315	$809,000	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.07%	170,404	$791,000	—	31 Mar 2022	13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	13F	Company	0.07%	168,552	$782,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.06%	152,209	$707,000	—	31 Mar 2022	13F
WOLVERINE ASSET MANAGEMENT LLC	13F	Company	0.06%	149,601	$694,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.05%	139,899	$649,000	—	31 Mar 2022	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.05%	117,415	$545,000	—	31 Mar 2022	13F
ARISTEIA CAPITAL, L.L.C.	13F	Company	0.04%	115,951	$538,000	—	31 Mar 2022	13F
Man Group plc	13F	Company	0.04%	112,903	$524,000	—	31 Mar 2022	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	107,000	$496,000	—	31 Mar 2022	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.04%	106,900	$496,000	—	31 Mar 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.04%	106,500	$494,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	97,136	$451,000	—	31 Mar 2022	13F
Daiwa Securities Group Inc.	13F	Company	0.03%	90,000	$417,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	88,323	$410,000	—	31 Mar 2022	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.03%	72,524	$337,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.02%	62,112	$288,000	—	31 Mar 2022	13F
LAZARD ASSET MANAGEMENT LLC	13F	Company	0.02%	56,427	$261,000	—	31 Mar 2022	13F

Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q2 2022

As of 30 Jun 2022, Esperion Therapeutics, Inc. - COM (ESPR) was held by 128 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,366,705 shares. The largest 10 holders included WASATCH ADVISORS INC, Deep Track Capital, LP, Meditor Group Ltd, VANGUARD GROUP INC, BlackRock Inc., Bellevue Group AG, MILLENNIUM MANAGEMENT LLC, Ikarian Capital, LLC, PLATINUM INVESTMENT MANAGEMENT LTD, and Paradigm Biocapital Advisors LP. This page lists 128 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

121

Q2 2022 holders

128

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.